• Antioxidant effect: Myricetin is a strong antioxidant, and oxidative stress plays a key role in various neurological diseases, including ischemia and senile dementia. Myricetin reduces β-amylase production and toxicity through conformational changes, which can be used to evaluate the progression of Alzheimer's disease.
•  Antitumor effect: Myricetin is an effective chemical control agent for carcinogenic effects.
•  Reduce neurotoxicity: Myricetin can protect neurons by inhibiting neurotoxicity caused by glutamate through different ways, so as to effectively prevent nerve damage.
• Effect on lymphocyte activation and proliferation: Myricetin can inhibit the expression of CD69, an early activation index of T cells, and inhibit lymphocyte proliferation.
•  Antagonism of platelet activating factor (PAF) : Myricetin inhibited PAF-induced WRP aggregation and 52H release in vitro in a concentration-dependent manner. At the same time, it can inhibit the increase of free calcium in platelets caused by PAF. Therefore, myricetin has many cardiovascular pharmacological effects such as anti-thrombus, anti-myocardial ischemia and improving microcirculation.
• Hypoglycemic effect: Myricetin has obvious hypoglycemic effect.
• Protecting the liver and protecting the liver: dihydromycetin can significantly inhibit the activity of alanine aminotransferase (ALT) and aspartase aminotransferase (AST) in serum and reduce the serum total bilirubin, which has an obvious effect on reducing enzyme and deyelination.

Changsha Staherb Natural Ingredients Co., LTD. service hotline: +86-13657431735 sales05@staherb.cn